Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome

NCT05250791 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Quality of Life
Recurrent Cancer

Interventions

DRUG: Lidocaine hydrochloride 2% for injection
DRUG: 0.9% sterile Sodium Chloride solution for injection

Sponsor

Imperial College London